Company Overview
PULMONX CORP
LUNGRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
90M
2025 FY
Net Income
-54M
2025 FY
Shares Outstanding
41M
2025 FY
EPS
-1.33USD
2025 FY
Company Information
SIC Code
3841
CIK Code
1127537
Exchange
Nasdaq
Location
US